ArticleArchives of medical research2020

Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?

Irene Karampela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.